AIAI logo

NetraMark Holdings Inc. Stock Price

TSX:AIAI Community·CA$87.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

AIAI Share Price Performance

CA$0.91
-0.40 (-30.53%)
CA$0.91
-0.40 (-30.53%)
Price CA$0.91

AIAI Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

NetraMark Holdings Inc. Key Details

CA$165.3k

Revenue

CA$0

Cost of Revenue

CA$165.3k

Gross Profit

CA$6.0m

Other Expenses

-CA$5.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.063
100.00%
-3,511.44%
0%
View Full Analysis

About AIAI

Founded
2016
Employees
n/a
CEO
George Achilleos
WebsiteView website
www.netramark.com

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

Recent AIAI News & Updates

Recent updates

No updates